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Initial Experience in Endovenous Laser Ablation (EVLA) of Varicose
Veins Due to Small Saphenous Vein Reflux
Theivacumar N.S., Beale R.J., Mavor A.I.D., Gough M.J. Eur J Vasc
Endovasc Surg 2007;33:614-8.
Objective Conventional surgery for varicose veins due to small saphe-
nous reflux is associated with high recurrence rates (up to 50%), many
resulting from inadequate surgery. This prospective audit examines the
safety and efficacy of EVLA in the treatment of this.
Method 65 patients (68 limbs) with varicosities due to primary or
recurrent sapheno-popliteal junction (SPJ) and small saphenous vein
(SSV) reflux underwent out-patient EVLA (810 nm diode laser). The
SSV was ablated from mid-calf to the SPJ. Symptomatic improvement
(Aberdeen Varicose Vein Severity Score [AVVSS]), time to return to
normal activity, post-EVLA analgesic requirements, and complications
were recorded.
ResultsDuplex ultrasound follow-up (median 6-months) confirmed
abolition of SPJ/SSV reflux in all limbs following a median total laser
energy delivery of 1131J (IQR 928-1364) at an energy density of 66.3
Joules/cm (IQR 54.2–71.6). AVVSS improved from 15.4 (IQR 11.8–
19.7) to 4.6 (IQR 3.2–6.7) at three months (p0.001). Median analge-
sia requirement was 3 days (23% [15/65] patients required none) and the
median time to normal activity was 0 (0–4) days (65% [42/65] returning
to normal daily activity immediately). There were no instances of skin
burns or DVT but 3 patients (4.4%) developed transient cutaneous
numbness (sural nerve). 98% (64/65) patients would undergo EVLT
again.
Conclusions EVLA abolished SPJ/SSV reflux in all limbs. This is
likely to be more effective than conventional surgery, although long-term
follow up is required. Data from a randomised control trial would be
desirable.
Foam Sclerotherapy Combined with Surgical Treatment for Recurrent
Varicose Veins: Short Term Results
Creton D., Uhl J.F. Eur J Vasc Endovasc Surg 2007;33:619-24.
Objective To study the short term results of combined peroperative
foam sclerotherapy (PFS) and surgical treatment for recurrent varicose veins.
Methods PFS was used to treat 129 limbs with recurrent varices: 100
great saphenous (GSV), 29 small saphenous veins (SSV). Foamwas prepared
with 1% polidocanol mixed with 4 times its volume of air. The 100 GSVs
comprised 28 trunks directly connected with the femoral vein, 28 connected
to a lymph node venous network, 11 associated with perforators and 33
isolated trunks. The 29 SSVs comprised 4 trunks directly connected to the
popliteal vein, 7 isolated trunks, 15 popliteal perforators and 3 recanalisa-
tions after SSV stripping. All operations included phlebectomies. In twenty
limbs re-ligation of the SFJ and 4 SPJs was carried out. All were performed
under local anaesthesia in an ambulatory setting. Patients were assessed
clinically and by colour duplex ultrasound after 3 and 40 days follow-up.
Results 120 patients (93%) showed complete obliteration of saphe-
nous trunks, junctions and varices. The 9 incomplete obliterations were 3
venous recanalisations in the SSV compartment and 6 perforators (4 popli-
teal and 2 femoral). Two asymptomatic deep venous thromboses were
detected by colour duplex 3 days after operation.
Conclusion PFS facilitates surgical treatment of recurrent varicose
veins. There is a small risk of post-operative deep vein thrombosis.
Randomised Clinical Trial of the Duration of Compression Therapy
after Varicose Vein Surgery
Biswas S., Clark A., Shields D.A. Eur J Vasc Endovasc Surg 2007;33:631-7.
Objective To determine whether a period of one or three weeks of
compression following varicose vein surgery influenced the outcome.
Design Randomised controlled trial.
Method 300 patients aged between 18–80 years underwent unilat-
eral varicose vein surgery in a Day Procedure Unit. Compression ban-
daging was applied post-operatively for three days. Patients then wore
graduated elastic compression stockings randomised to a period of either
one or three weeks. Patients were assessed by questionnaire on pain
scores at rest and during mobilisation for up to six weeks, total analgesic
consumption, duration of time off work, any complications, and patient
perception of cosmetic results at various periods up to 12 weeks following
surgery.
Results The mean pain score reported by patients over 6 weeks was
similar in the two groups (1 week group: mean 2.18, three week group:
mean 1.87). The 95% confidence interval (CI) for the mean difference in
pain was (0.05–0.66). Analysis of the pain curves at 1 week, 4 weeks and
6 weeks, showed equivalence at 4 and 6 weeks, but not for 1 week, with the
groupwearing stockings for only one week complaining ofmore pain for this
period. A significant increase in the total number of analgesia tablets con-
sumed was also found in the group wearing stockings for only one week. No
significant differences were found in the other secondary endpoints – return
to work (categorised as 2 weeks, 2–6 weeks or 6–12 weeks), patient
satisfaction or post-operative complications.
ConclusionWe found no benefit in wearing compression stockings for
more than one week following uncomplicated high saphenous ligation with
stripping of the great saphenous vein with respect to post-operative pain,
number of complications, time to return to work, or patient satisfaction for
up to 12 weeks following surgery.
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